PHARMACEUTICAL DOSAGE FORMS COMPRISING SODIUM-1-[6-(MORPHOLIN-4-YL)PYRIMIDIN-4-YL]-4-(1H-1,2,3-TRIAZOL-1-YL)-1H-PYRAZOL-5-OLATE

• 收藏
• 分享

专利权人:

BAYER PHARMA AKTIENGESELLSCHAFT

发明人:

Heike NEUMANN,Klaus BENKE,Michael FORMELL,Gabriele WINTER

申请号：

US15029215

公开号：

US20160256394A1

申请日:

2014.10.13

申请国别(地区):

US

年份:

2016

代理人:

摘要：

The present invention relates to solid pharmaceutical dosage forms for oral administration comprising sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate (active ingredient (I)), characterized in that the active ingredient (I) is released, and also methods for the preparation thereof, use thereof as medicaments, and also use thereof for prophylaxis, secondary prophylaxis or treatment of disorders, particularly cardiovascular disorders, heart failure, anaemia, chronic renal disorders and renal insufficiency.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/